How to Effectively Respond to Ethics Committee Queries in Clinical Trials

During the review of clinical trial submissions, Ethics Committees (ECs) or Institutional Review Boards (IRBs) often raise queries or request clarifications before granting approval. How you respond to these queries is crucial. A prompt, clear, and well-structured response demonstrates professionalism, ensures compliance, and minimizes delays. This tutorial outlines a step-by-step approach to effectively addressing EC queries in line with regulatory expectations.

Understanding the Purpose of EC Queries:

Ethics Committee queries aim to:

• Ensure participant safety and informed consent
• Clarify inconsistencies in protocol or documents
• Assess investigator qualifications and trial conduct plans
• Ensure compliance with local and international regulations (e.g., USFDA, CDSCO)

Queries are not rejections but rather opportunities to improve submission clarity and ethics compliance.

Common Types of Ethics Committee Queries:

• Language issues or ambiguity in the Informed Consent Form (ICF)
• Lack of clarity in study methodology
• Inadequate justification for risk-benefit balance
• Missing or outdated investigator credentials
• Requests for translation certificates, indemnity insurance, or approvals from other authorities

Step-by-Step Process for Responding to EC Queries:

1. Acknowledge Receipt Promptly

• Send an acknowledgment email within 24 hours of receiving EC queries
• Confirm intended timeline for response submission

2. Review and Categorize the Queries

• Group queries by topic (e.g., ICF, protocol design, investigator documents)
• Assign each category to the responsible department or stakeholder
• Note any queries that may require regulatory or sponsor input

Document each query-response cycle in a GMP audit-ready format.

3. Draft a Structured Point-by-Point Response

Each query should be restated, followed by a concise, factual response:

• Quote the query exactly as written by the EC
• Provide a clear, professional response below it
• Reference revised documents by name and version (e.g., Protocol V2.0, dated 21-June-2025)

Example:
EC Query #3: Please clarify the definition of ‘serious adverse event’ used in the protocol.
Response: Section 10.1 of the revised protocol (V2.0) now includes a detailed definition in line with ICH-GCP E6(R2) guidelines.

4. Update and Attach Required Documents

• Include both tracked and clean versions of revised documents
• Ensure all updates reflect consistent formatting and version control
• Ensure signatures, seals, and dates are correctly placed

Use templates from pharma SOP documentation standards to avoid inconsistencies.

5. Cross-Check Against a Response Checklist

Before submission, ensure:

• All queries are addressed without omissions
• Responses are supported by appropriate documentation
• Contact person is listed for follow-up

6. Submit the Response Package

• Follow the EC’s submission protocol (physical submission, email, or online portal)
• Label the response as “Point-by-Point Clarification to EC Queries – [Trial Title]”
• Maintain a submission log with time, date, courier receipt, or submission confirmation

Best Practices for EC Communication:

• Be concise yet thorough
• Use non-defensive, factual language
• Maintain professional formatting (headers, numbered bullets)
• Avoid over-explaining or including unnecessary attachments
• Submit within the deadline specified by the EC (usually 7–21 days)

Tools to Manage EC Query Responses:

Effective query management tools and logs may include:

• Excel-based EC Query Tracker
• CTMS modules with document linking
• Query Response SOPs for study teams
• Version-controlled folders and submission templates

Organize query response logs alongside stability studies documentation to streamline compliance audits.

Common Pitfalls to Avoid:

• Ignoring a query or submitting a partial response: Always respond comprehensively
• Missing the submission deadline: Leads to delays or study rejection
• Incorrect version control: Use clear file names and dates
• Informal language: All communication must be professional and audit-ready

Post-Submission Follow-Up:

• Track EC meeting dates for review of your responses
• Send a reminder if no acknowledgment is received within 3–5 business days
• Update site team and sponsor with response status

Documentation and Filing:

• Store all query letters, responses, and EC acknowledgments in the Investigator Site File (ISF)
• Ensure consistency with regulatory binders and audit logs
• Maintain digital backups and print copies as per institutional SOP

Update the validation documentation if any procedural changes are made post-EC clarification.

Conclusion:

Responding to Ethics Committee queries is an essential part of clinical trial governance. Clear, structured, and timely responses not only expedite approvals but also reflect the sponsor’s or site’s commitment to ethical research. By adhering to these best practices and leveraging SOPs, version control systems, and compliance tools, clinical professionals can maintain a smooth and audit-ready EC communication workflow throughout the trial lifecycle.